Strides Pharma Science Limited

NSEI:STAR Lagerbericht

Marktkapitalisierung: ₹128.0b

Strides Pharma Science Management

Management Kriterienprüfungen 3/4

Strides Pharma Science CEO ist Badree Komandur , ernannt in Jun 2024, hat eine Amtszeit von weniger als einem Jahr. Die jährliche Gesamtvergütung beträgt ₹44.00M , bestehend aus 83% Gehalt und 17% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.027% der Aktien des Unternehmens, im Wert von ₹37.60M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 0.4 Jahre bzw. 6.2 Jahre.

Wichtige Informationen

Badree Komandur

Geschäftsführender

₹44.0m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts83.0%
Amtszeit als Geschäftsführerless than a year
Eigentum des Geschäftsführers0.03%
Durchschnittliche Amtszeit des Managementsless than a year
Durchschnittliche Amtszeit der Vorstandsmitglieder6.2yrs

Jüngste Management Updates

Recent updates

Strides Pharma Science's (NSE:STAR) Solid Earnings Are Supported By Other Strong Factors

Nov 01
Strides Pharma Science's (NSE:STAR) Solid Earnings Are Supported By Other Strong Factors

Why Investors Shouldn't Be Surprised By Strides Pharma Science Limited's (NSE:STAR) 27% Share Price Surge

Oct 21
Why Investors Shouldn't Be Surprised By Strides Pharma Science Limited's (NSE:STAR) 27% Share Price Surge

After Leaping 29% Strides Pharma Science Limited (NSE:STAR) Shares Are Not Flying Under The Radar

Aug 14
After Leaping 29% Strides Pharma Science Limited (NSE:STAR) Shares Are Not Flying Under The Radar

Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)

Apr 04
Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Feb 29
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

Dec 23
Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt

Sep 26
We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Jun 08
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Aug 02
Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Is Strides Pharma Science (NSE:STAR) A Risky Investment?

Jun 25
Is Strides Pharma Science (NSE:STAR) A Risky Investment?

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Dec 21
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Jul 28
Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)

Apr 13
Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)

Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?

Mar 04
Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?

These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively

Feb 15
These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively

Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?

Jan 26
Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?

The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It

Jan 11
The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Badree Komandur im Vergleich zu den Einnahmen von Strides Pharma Science verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

₹2b

Jun 30 2024n/an/a

-₹475m

Mar 31 2024₹44m₹37m

-₹1b

Dec 31 2023n/an/a

-₹2b

Sep 30 2023n/an/a

-₹2b

Jun 30 2023n/an/a

-₹924m

Mar 31 2023₹44m₹36m

-₹2b

Dec 31 2022n/an/a

-₹2b

Sep 30 2022n/an/a

-₹2b

Jun 30 2022n/an/a

-₹4b

Mar 31 2022₹46m₹38m

-₹5b

Dec 31 2021n/an/a

-₹4b

Sep 30 2021n/an/a

-₹3b

Jun 30 2021n/an/a

-₹543m

Mar 31 2021₹44m₹33m

₹3b

Dec 31 2020n/an/a

₹28m

Sep 30 2020n/an/a

₹589m

Jun 30 2020n/an/a

₹1b

Mar 31 2020₹37m₹23m

₹492m

Dec 31 2019n/an/a

₹3b

Sep 30 2019n/an/a

₹2b

Jun 30 2019n/an/a

₹745m

Mar 31 2019₹32m₹18m

₹840m

Dec 31 2018n/an/a

-₹93m

Sep 30 2018n/an/a

₹139m

Jun 30 2018n/an/a

₹415m

Mar 31 2018₹26m₹17m

₹544m

Vergütung im Vergleich zum Markt: BadreeDie Gesamtvergütung ($USD520.74K) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt Indian ($USD503.20K).

Entschädigung vs. Einkommen: BadreeDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Badree Komandur (52 yo)

less than a year

Amtszeit

₹44,000,000

Vergütung

Mr. Badree Komandur had been the Chief Financial Officer and Executive Director of Finance of Strides Pharma Science Limited (formerly known as Strides Shasun Limited) since August 1, 2013 until June 1, 20...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Arun Pillai
Founder & Executive Chairperson34.4yrs₹120.00m2.11%
₹ 2.7b
Badree Komandur
MD & Group CEOless than a year₹44.00m0.027%
₹ 34.8m
Manjula Ramamurthy
Compliance Officer & Company Secretary7.8yrs₹6.85mkeine Daten
Aditya Kumar
Executive Director of Business Development & Directorless than a year₹7.50m0.064%
₹ 81.3m
Vikesh Kumar
Group CFO & Chief Investor Relations Officerless than a yearkeine Datenkeine Daten
P. V. Ramaraju
Chief Operating Officerless than a yearkeine Datenkeine Daten
Sormistha Ghosh
Group General Counselno datakeine Datenkeine Daten
Surabhi Loshali
Group Chief Human Resource Officerno datakeine Datenkeine Daten
C. Sundar
Executive Vice President of Operationsno datakeine Datenkeine Daten
Kevin Cook
Senior Vice President of Strides Pharma Inc.no datakeine Datenkeine Daten
Umesh Kale
Chief Quality Officerno datakeine Datenkeine Daten
A. Narayanan
Chief Information Technology Officerno datakeine Datenkeine Daten

0.4yrs

Durchschnittliche Betriebszugehörigkeit

48yo

Durchschnittliches Alter

Erfahrenes Management: STARDas Führungsteam des Unternehmens gilt nicht als erfahren ( 0.4 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Arun Pillai
Founder & Executive Chairperson34.4yrs₹120.00m2.11%
₹ 2.7b
Badree Komandur
MD & Group CEO7.5yrs₹44.00m0.027%
₹ 34.8m
Aditya Kumar
Executive Director of Business Development & Directorless than a year₹7.50m0.064%
₹ 81.3m
Homi Khusrokhan
Independent Director7.5yrs₹4.00mkeine Daten
Dennis Bastas
Executive Chairman of Arrow Pharmaceuticals Pty Ltdno datakeine Datenkeine Daten
Gopakumar Nair
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Elias Neto
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
S. Vyas
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
B. Suresh
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
C. Gupta
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Kausalya Santhanam
Independent Director4.9yrs₹4.00m0.0024%
₹ 3.1m
Ameet Hariani
Independent Directorless than a year₹800.00kkeine Daten

6.2yrs

Durchschnittliche Betriebszugehörigkeit

62.5yo

Durchschnittliches Alter

Erfahrener Vorstand: STARDie Vorstandsmitglieder gelten als erfahren (6.2 Jahre durchschnittliche Amtszeit).